Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
AssigneeZentaris AG
InventorsMarcus Karl Koppitz, Hans Peter Muhn, Kenneth Jay Shaw, Holger Hess-Stumpp, Klaus Wolfgang Paulini
Life of this patent
Estimating the term…
Loading patent…
AssigneeZentaris AG
InventorsMarcus Karl Koppitz, Hans Peter Muhn, Kenneth Jay Shaw, Holger Hess-Stumpp, Klaus Wolfgang Paulini
Estimating the term…
This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A pharmaceutical composition that contains these new tetrahydrocarbazole derivatives as well as a process for the production of the new tetrahydrocarbazole derivatives are also provided. Moreover, this invention relates to the administration of tetrahydrocarbazole derivatives for treating pathologic conditions that are mediated by GPCR, especially for inhibiting GnRH, in mammals, especially humans, who require such an administration, as well as the use of tetrahydrocarbazole derivatives for the production of a pharmaceutical agent for treating GPCR-mediated pathologic conditions, especially for inhibiting GnRH.
Compound of general formula (I)
Dependencies are inferred from the claim text.